1. Expression of Myoglobin in Normal and Cancer Brain Tissues: Correlation With Hypoxia Markers
   Marwa E. Elsherbiny et al, 2021, Frontiers in Oncology CrossRef
2. Myoglobin: From physiological roles to potential implications in cancer
   Islam E. Elkholi et al, 2022, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
3. Hypoxia inducible factor down-regulation, cancer and cancer stem cells (CSCs): ongoing success stories
   Anthony R. Martin et al, 2017, MedChemComm CrossRef
4. Repurposing some older drugs that cross the blood–brain barrier and have potential anticancer activity to provide new treatment options for glioblastoma
   Dayle Rundle‐Thiele et al, 2016, British Journal of Clinical Pharmacology CrossRef
5. Increased expression of MMP-2 and MMP-9 indicates poor prognosis in glioma recurrence
   Wei Zhou et al, 2019, Biomedicine & Pharmacotherapy CrossRef
6. Identification of established and novel extracellular matrix components in glioblastoma as targets for angiogenesis and prognosis
   Lucas Cunha Barbosa et al, 2024, Neurogenetics CrossRef
7. Homeostatic Regulation of Pro-Angiogenic and Anti-Angiogenic Proteins via Hedgehog, Notch Grid, and Ephrin Signaling in Tibial Dyschondroplasia
   Shah Nawaz et al, 2023, Animals CrossRef
8. Targeting the NF-E2-related factor 2 pathway: A novel strategy for glioblastoma (Review)
   JIANHONG ZHU et al, 2014, Oncology Reports CrossRef
9. Hypoxia: A Potent Regulator of Angiogenesis Through Extracellular Matrix Remodelling
   Katerina Karavasili et al, 2023, Matrix Pathobiology and Angiogenesis CrossRef
10. In Vivo Relationship Between Hypoxia and Angiogenesis in Human Glioblastoma: A Multimodal Imaging Study
    Keven Ferreira da Ponte et al, 2017, Journal of Nuclear Medicine CrossRef
11. Pro- and Antiangiogenic Factors in Gliomas: Implications for Novel Therapeutic Possibilities
    Magdalena Groblewska et al, 2021, International Journal of Molecular Sciences CrossRef